204 related articles for article (PubMed ID: 8882606)
21. Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.
Mong S; Chi-Rosso G; Miller J; Hoffman K; Razgaitis KA; Bender P; Crooke ST
Mol Pharmacol; 1986 Sep; 30(3):235-42. PubMed ID: 3018480
[TBL] [Abstract][Full Text] [Related]
22. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
Tsai BS; Villani-Price D; Keith RH; Zemaitis JM; Bauer RF; Leonard R; Djuric SW; Shone RL
Prostaglandins; 1989 Dec; 38(6):655-74. PubMed ID: 2561214
[TBL] [Abstract][Full Text] [Related]
23. The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930.
Penning TD; Djuric SW; Docter SH; Yu SS; Spangler D; Anglin CP; Fretland DJ; Kachur JF; Keith RH; Tsai BS
Agents Actions; 1993; 39 Spec No():C11-3. PubMed ID: 8273545
[TBL] [Abstract][Full Text] [Related]
24. Antagonizing leukotriene B4 receptors delays cardiac allograft rejection in mice.
Weringer EJ; Perry BD; Sawyer PS; Gilman SC; Showell HJ
Transplantation; 1999 Mar; 67(6):808-15. PubMed ID: 10199727
[TBL] [Abstract][Full Text] [Related]
25. Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships.
Daines RA; Chambers PA; Pendrak I; Jakas DR; Sarau HM; Foley JJ; Schmidt DB; Kingsbury WD
J Med Chem; 1993 Oct; 36(22):3321-32. PubMed ID: 8230122
[TBL] [Abstract][Full Text] [Related]
26. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
[TBL] [Abstract][Full Text] [Related]
27. Functional properties of guinea pig eosinophil leukotriene B4 receptor.
Ng CF; Sun FF; Taylor BM; Wolin MS; Wong PY
J Immunol; 1991 Nov; 147(9):3096-103. PubMed ID: 1655904
[TBL] [Abstract][Full Text] [Related]
28. 20-Hydroxy- and 20-carboxy-leukotriene (LT) B
Archambault AS; Poirier S; Lefebvre JS; Robichaud PP; Larose MC; Turcotte C; Martin C; Provost V; Boudreau LH; McDonald PP; Laviolette M; Surette ME; Flamand N
J Leukoc Biol; 2019 Jun; 105(6):1131-1142. PubMed ID: 30676680
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists.
Jackson WT; Boyd RJ; Froelich LL; Gapinski DM; Mallett BE; Sawyer JS
J Med Chem; 1993 Jun; 36(12):1726-34. PubMed ID: 8389876
[TBL] [Abstract][Full Text] [Related]
30. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4.
Matsukawa A; Hogaboam CM; Lukacs NW; Lincoln PM; Strieter RM; Kunkel SL
J Immunol; 1999 Dec; 163(11):6148-54. PubMed ID: 10570305
[TBL] [Abstract][Full Text] [Related]
31. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
32. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
33. ONO-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions.
Kishikawa K; Tateishi N; Maruyama T; Seo R; Toda M; Miyamoto T
Prostaglandins; 1992 Oct; 44(4):261-75. PubMed ID: 1332129
[TBL] [Abstract][Full Text] [Related]
34. Essential fatty acids are antagonists of the leukotriene B4 receptor.
Yagaloff KA; Franco L; Simko B; Burghardt B
Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):293-7. PubMed ID: 7630916
[TBL] [Abstract][Full Text] [Related]
35. Leukotriene B4 and leukotriene B5 have binding sites on lung membranes and cause contraction of bullfrog lung.
Andazola JJ; Underwood JA; Chiono M; Torres OA; Herman CA
J Pharmacol Exp Ther; 1992 Dec; 263(3):1111-7. PubMed ID: 1335056
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of 20-trifluoromethyl leukotriene B4 on human neutrophil functions.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Bauer RF; Leonard R; Abe Y; Nicolaou KC
Prostaglandins; 1989 Feb; 37(2):287-302. PubMed ID: 2543037
[TBL] [Abstract][Full Text] [Related]
37. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK
J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of LTB4 binding to human neutrophils by nordihydroguaiaretic acid.
Maloff BL; Fefer D; Cooke GM; Ackerman NR
Agents Actions; 1987 Aug; 21(3-4):358-60. PubMed ID: 2825484
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analogues.
Boehm JC; Gleason JG; Pendrak I; Sarau HM; Schmidt DB; Foley JJ; Kingsbury WD
J Med Chem; 1993 Oct; 36(22):3333-40. PubMed ID: 8230123
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.
Ohmi N; Tani C; Yamada K; Fukui M
Inflammation; 1994 Apr; 18(2):129-40. PubMed ID: 8070898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
